Next generation sequencing (NGS) has been an invaluable tool to put genomic sequencing
into clinical practice. The incorporation of clinically relevant target sequences into NGS …

Gastric cancer (GC) remains the fifth most prevalent cancer worldwide and the third leading
cause of global cancer mortality. Comprehensive‐omic studies have unveiled a …

The most recent version of the European Society for Medical Oncology (ESMO) Clinical
Practice Guidelines for the diagnosis, treatment and follow-up of gastric cancer (GC) was …

Introduction Gastric cancer (GC) is the third leading cause of cancer-related deaths in China
and immunotherapy emerging as a revolutionary treatment for GC recently. Tumor …

Simple Summary Germline BRCA1 and BRCA2 pathogenic variant carriers are recognized
to be at increased risk for multiple cancers including breast, ovarian, pancreatic, and …

Esophageal, esophago-gastric, and gastric cancers are major causes of cancer morbidity
and cancer death. For patients with potentially resectable disease, multi-modality treatment …

Gastric Cancer (GC) is a complex and heterogeneous disease, which represents a global
health concern. Despite advances in prevention, diagnosis, and therapy, GC is still a leading …

Gastric cancer (GC) remains one of the most common malignances and the leading cause of
cancer-related mortality worldwide. Although the critical role of several long non-coding …

Background Recent progress in genomic analysis using next-generation sequencing
technology has enabled the comprehensive detection of mutations and tumor mutation …

Modern omics technologies can generate massive amounts of biomedical data, providing
unprecedented opportunities for individualized precision medicine. However, traditional …